Details

NameSymbolSector
ERIS LIFESCIENCES LIMITEDERISPharmaceuticals
Open
1351.8
High
1351.8
Low
1276.7
Close
1298.2
Volume
205381
Exchange
bse
Time
30-Mar-2026

Outlook

Score:  

3.25

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Eris Lifesciences is  
Long Body
Estimated Stoploss of Eris Lifesciences is ₹  
1351.8
Eris Lifesciences has a  
Bearishℹ
 pattern. 
Formation of  
Long Body
 candle pattern indicates the trend direction of Eris Lifesciences maybe  
Unpredictableℹ
, but keep a lookout for fall in price. 

Trend

Eris Lifesciences is in  
Sideways trendℹ
. 
Price of Eris Lifesciences is  
Downℹ
 by  

4.43

%. 
Target
Buy @ 

1241.03

Sell @ 

1548.41

Current @ 

1298.2

Volume

The trades of Eris Lifesciences have been in  
Immenseℹ
 volume. 
The volume trades for Eris Lifesciences are  
Bearishℹ
 with  
Strong Sellersℹ
The trade volume of Eris Lifesciences is  

Up

 by  

189.53

% 

Valuation

The current market price of Eris Lifesciences is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 7033cr and total assets worth ₹ 7033cr, the balance sheet of Eris Lifesciences is:  
Balancedℹ
. 
Cashflow
Eris Lifesciences has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 105cr

. It is  
Upℹ
 by  

854.55

%. 

(*Mar 2025)

52.57% i.e. ₹ 1065cr earned in operatingℹ
3.9% i.e. ₹ 79cr spent in investingℹ
43.48% i.e. ₹ 881cr spent in financingℹ
0.05% i.e. ₹ 1cr earned in otherℹ
Eris Lifesciences has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 11cr

. It is  
Upℹ
 by  

120

%. 

(*Mar 2024)

13.07% i.e. ₹ 486cr earned in operatingℹ
49.85% i.e. ₹ 1854cr spent in investingℹ
37.08% i.e. ₹ 1379cr earned in financingℹ
0% in otherℹ
Income
The income of Eris Lifesciences is  

₹ 795cr

 and  

Profit

 is :  

₹ 134cr

(*Sep 2025)

Eris Lifesciences Profit is up by:  

8.06

% and Income is Up by:  

2.58

% 

(*Sep 2025)

The income of Eris Lifesciences is  

₹ 775cr

 and  

Profit

 is :  

₹ 124cr

(*Jun 2025)

Eris Lifesciences Profit is up by:  

21.57

% and Income is Up by:  

8.7

% 

(*Jun 2025)

The income of Eris Lifesciences is  

₹ 713cr

 and  

Profit

 is :  

₹ 102cr

(*Mar 2025)

Eris Lifesciences Profit is up by:  

18.6

% and Income is Down by:  

2.46

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.